Literature DB >> 31961217

Outcome and Metastatic Behavior of Canine Sinonasal Osteosarcoma (2005-2015).

Annie Galloway1, Susan Lana1, Doug Thamm1, Keara Boss1.   

Abstract

Sinonasal neoplasms in dogs behave locally aggressively, and metastatic disease has not been a common cause of death. The metastatic rate of sinonasal osteosarcoma (OSA) is not well characterized, and reported outcomes of these patients are variable. The purpose of this study is to evaluate the outcome and metastatic behavior of canine sinonasal OSA. Medical records of canine patients diagnosed with sinonasal OSA via histopathology between January 2005 and December 2015 were reviewed. Patients with any form of treatment or no treatment were included. Time to local progression, time to metastasis, and overall survival data were evaluated. Variables that may impact outcome, such as tumor stage and treatment type, were evaluated. Twenty-seven dogs were identified that fit the inclusion criteria. Overall, 30.0% of dogs developed metastasis over the disease course, with a median time to metastasis of 458 days (95% confidence interval [CI] 318-758 days). The median time to local progression was 335 days (95% CI 264-544 days). The overall median survival time was 410 days (95% CI 341-627 days). Regarding metastasis, sinonasal OSA behaves similarly to sinonasal neoplasms of other histologies and dissimilarly to appendicular OSA. The outcome of treated patients appears similar to that of sinonasal tumor patients with other histologies.

Entities:  

Year:  2020        PMID: 31961217     DOI: 10.5326/JAAHA-MS-6972

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  2 in total

1.  Relative tumor volume has prognostic relevance in canine sinonasal tumors treated with radiation therapy: A retrospective study.

Authors:  Felicitas Czichon; Carla Rohrer Bley; Valeria Meier
Journal:  PLoS One       Date:  2022-05-27       Impact factor: 3.752

2.  Outcome of external beam radiotherapy for treatment of noncutaneous tumors of the head in horses: 32 cases (1999-2015).

Authors:  Alex Gillen; Margaret Mudge; Fred Caldwell; Amelia Munsterman; Reid Hanson; William Brawner; Gregory Almond; Eric Green; Julie Stephens; Jillian Walz
Journal:  J Vet Intern Med       Date:  2020-11-09       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.